FI103986B1 - cDNA-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-växtfaktoraktivitet - Google Patents

cDNA-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-växtfaktoraktivitet

Info

Publication number
FI103986B1
FI103986B1 FI862674A FI862674A FI103986B1 FI 103986 B1 FI103986 B1 FI 103986B1 FI 862674 A FI862674 A FI 862674A FI 862674 A FI862674 A FI 862674A FI 103986 B1 FI103986 B1 FI 103986B1
Authority
FI
Finland
Prior art keywords
cdna
factor activity
growth factor
eosinophilic
cdna clones
Prior art date
Application number
FI862674A
Other languages
English (en)
Finnish (fi)
Other versions
FI862674A0 (fi
FI862674A (fi
FI103986B (sv
Inventor
Takasi Yokota
Frank Don Lee
Donna Maye Rennick
Ken-Ichi Arai
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of FI862674A0 publication Critical patent/FI862674A0/fi
Publication of FI862674A publication Critical patent/FI862674A/fi
Application granted granted Critical
Publication of FI103986B publication Critical patent/FI103986B/sv
Publication of FI103986B1 publication Critical patent/FI103986B1/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
FI862674A 1984-11-20 1986-06-24 cDNA-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-växtfaktoraktivitet FI103986B1 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67389884A 1984-11-20 1984-11-20
US67389884 1984-11-20
US8502250 1985-11-18
PCT/US1985/002250 WO1986003225A1 (en) 1984-11-20 1985-11-18 cDNA CLONES CODING FOR POLYPEPTIDES EXHIBITING HUMAN GRANULOCYTE MACROPHAGE AND EOSINOPHIL CELLULAR GROWTH FACTOR ACTIVITY

Publications (4)

Publication Number Publication Date
FI862674A0 FI862674A0 (fi) 1986-06-24
FI862674A FI862674A (fi) 1986-06-24
FI103986B FI103986B (sv) 1999-10-29
FI103986B1 true FI103986B1 (sv) 1999-10-29

Family

ID=24704538

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862674A FI103986B1 (sv) 1984-11-20 1986-06-24 cDNA-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-växtfaktoraktivitet

Country Status (26)

Country Link
EP (1) EP0202300B1 (sv)
JP (1) JP3038348B2 (sv)
KR (1) KR920003822B1 (sv)
CN (3) CN1031465C (sv)
AT (1) ATE82321T1 (sv)
AU (1) AU608741B2 (sv)
BG (1) BG60840B2 (sv)
DE (1) DE3586826T2 (sv)
DK (1) DK174598B1 (sv)
ES (1) ES8705470A1 (sv)
FI (1) FI103986B1 (sv)
GR (1) GR852786B (sv)
HK (1) HK6096A (sv)
HU (1) HU213226B (sv)
IE (1) IE59581B1 (sv)
IL (1) IL77080A (sv)
LU (1) LU88360I2 (sv)
MX (1) MX9203397A (sv)
MY (1) MY101971A (sv)
NL (1) NL930120I2 (sv)
NO (1) NO862903L (sv)
NZ (1) NZ214225A (sv)
OA (1) OA08671A (sv)
PT (1) PT81513B (sv)
WO (1) WO1986003225A1 (sv)
ZA (1) ZA858833B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
EP0238655A4 (en) * 1985-10-03 1989-09-11 Biogen Nv POLYPEPTIDES LIKE THE GRANULOCYTE-MACROPHOUS COLONY STIMULATION FACTORS (GM-CSF) AND THEIR METHODS OF PRODUCING LARGE QUANTITIES IN MICROBIAL CELLS.
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
JPS6420097A (en) * 1987-03-02 1989-01-24 Sumitomo Chemical Co Human granulocyte-macrophage colony stimulating factor
WO1988008428A1 (en) * 1987-04-28 1988-11-03 Amgen Inc. Method for purifying granulocyte/macrophage colony stimulating factor
AU626530B2 (en) * 1987-07-17 1992-08-06 Schering Biotech Corporation Human granulocyte-macrophage colony stimulating factor and muteins thereof
CA1335717C (en) * 1987-07-17 1995-05-30 Takashi Yokota Human granulocyte-macrophage colony stimulating factor and muteins thereof
GB2212159B (en) * 1987-11-13 1992-01-22 British Bio Technology Synthetic gene for human granulocyte/macrophage colony stimulating factor.
JPH03503897A (ja) * 1988-04-21 1991-08-29 メドベット・サイエンス・プロプライアテリー・リミテッド ひとｇｍ‐ｃｓｆ変異形類
US5109119A (en) * 1989-06-06 1992-04-28 Schering Corporation Crystalline r-h-gm-csf and method
KR100448021B1 (ko) * 2001-12-28 2004-09-08 크레아젠 주식회사 마우스 과립구 대식세포 콜로니 촉진인자 발현벡터 ｐＧＭ-ＣＳＦ로 형질전환된 대장균 및 상기 마우스 과립구 대식세포 콜로니 촉진인자의 대량생산방법
NZ539448A (en) * 2002-09-20 2008-03-28 Dendreon Corp Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated prostrate cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
NZ228031A (en) * 1984-07-06 1991-12-23 Sandoz Ltd Primate gm-csf and method of extraction
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene

Also Published As

Publication number Publication date
EP0202300A1 (en) 1986-11-26
FI862674A0 (fi) 1986-06-24
ATE82321T1 (de) 1992-11-15
NO862903D0 (no) 1986-07-18
JPS62501259A (ja) 1987-05-21
HU213226B (en) 1997-03-28
IL77080A (en) 1998-02-08
KR920003822B1 (ko) 1992-05-15
BG60840B2 (bg) 1996-04-30
OA08671A (en) 1989-03-31
FI862674A (fi) 1986-06-24
CN1020473C (zh) 1993-05-05
NO862903L (no) 1986-09-18
PT81513B (pt) 1988-03-03
CN85109132A (zh) 1986-12-03
ES8705470A1 (es) 1987-05-01
CN1086543A (zh) 1994-05-11
FI103986B (sv) 1999-10-29
GR852786B (sv) 1986-03-20
IL77080A0 (en) 1986-04-29
EP0202300B1 (en) 1992-11-11
PT81513A (en) 1985-12-01
AU5196386A (en) 1986-06-18
DK345286A (da) 1986-07-21
DK345286D0 (da) 1986-07-21
DE3586826D1 (de) 1992-12-17
DE3586826T2 (de) 1993-03-25
HK6096A (en) 1996-01-19
MY101971A (en) 1992-02-29
NZ214225A (en) 1991-05-28
IE852889L (en) 1986-05-20
CN1045539C (zh) 1999-10-13
ZA858833B (en) 1986-06-25
JP3038348B2 (ja) 2000-05-08
NL930120I2 (nl) 1994-07-01
CN1031465C (zh) 1996-04-03
KR860700359A (ko) 1986-10-06
DK174598B1 (da) 2003-07-14
NL930120I1 (nl) 1993-11-01
IE59581B1 (en) 1994-03-09
WO1986003225A1 (en) 1986-06-05
LU88360I2 (fr) 1994-05-04
AU608741B2 (en) 1991-04-18
ES548998A0 (es) 1987-05-01
MX9203397A (es) 1992-07-01
HUT40464A (en) 1986-12-28

Similar Documents

Publication Publication Date Title
FI103986B1 (sv) cDNA-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-växtfaktoraktivitet
GB2147585B (en) Cdna clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity
ES549539A0 (es) Un metodo para la preparacion de eritropoyetina.
KR900016465A (ko) 사람의 macif 활성을 지닌 단백질을 암호화하는 유전자, 이 유전자를 함유하는 발현벡터, 형질전환 세포 및 사람 macif활성을 갖는 단백질
ES8607392A1 (es) Un procedimiento para producir un polipeptido que exhibe ac-tividad de factor de fijacion de ige de mamifero
GB2314332A (en) Gene expression in mammalian cells

Legal Events

Date Code Title Description
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L165

Extension date: 20061107

FG Patent granted

Owner name: SCHERING BIOTECH CORPORATION

MA Patent expired